Blackstone Inc
CERE

Blackstone Inc’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Blackstone Inc’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-20,651
Closed -$844K – 187
2024
Q2 		$844K Sell
20,651
-14,545
-41% -$595K ﹤0.01% 135
2024
Q1 		$1.49M Buy
35,196
+20,651
+142% +$873K 0.01% 124
2023
Q4 		$617K Buy
+14,545
New +$617K ﹤0.01% 125